Neuroimaging of the effects of Deep Brain Stimulation in patients with Obsessive Compulsive Disorder.

Neuroimaging of the effects of Deep Brain Stimulation in patients with Obsessive Compulsive Disorder. - Neuroimaging of DBS in OCD.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31543

Enrollment

Registered

2008-05-26

Start date

2008-02-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder (OCD)

Interventions

Activity of the electrode system will be modulated during on and off situations of activity of the electrode.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Subjects have signed informed consent. - Neurostimulator has been implanted according to METC protocol number 04/113-E - Fulfilling in and exclusion criteria according METC protocol number 04/113-E - No use of psychotropic medication 4 weeks before the scan procedure.

Exclusion criteria

Exclusion criteria: - Participation in a SPECT of PET study in the year prior to this study. - Radiological workers - Use of drugs - Pregnancy - Use of tabacco, alcohol, coffee, tea and chocolate 24 hours before the scanning procedure, since brain metabolism may be influenced by these products.

Design outcomes

Primary

Measure	Time frame
fMRI will be used to determine alterations in cerebral perfusion IBZM SPECT will be used to determine alteration in D2 receptor binding.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)